Search

Search Results
Results 7941 - 7950 of 8185 for Skin Cancer
  • Vitiligo Treatment
    Health - 23 Aug 2018
    Vitiligo is a difficult condition to treat, but newer treatments are being researched all the time. The most common therapies may be classified as:
  • How Do We Sense Pain?
    Health - 6 Mar 2016
    Pain is a sensation that is triggered in the nervous system. It can be sharp or dull and last for short or long periods. Pain may be localized to a specific area of the body such as the abdomen, chest...
  • Trileptal
    Drug - 3 Oct 2024
    Consumer Medicine Information (CMI) about Trileptal (oxcarbazepine) intended for persons living in Australia.
  • Terimide
    Drug - 3 Oct 2024
    Consumer Medicine Information (CMI) about Terimide intended for persons living in Australia.
  • DBL Sulfamethoxazole and Trimethoprim
    Drug - 1 Oct 2024
    Consumer Medicine Information (CMI) about DBL Sulfamethoxazole and Trimethoprim intended for persons living in Australia.
  • Targocid
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Targocid intended for persons living in Australia.
  • Cosdor
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Cosdor (Dorzolamide hydrochloride/Timolol maleate) intended for persons living in Australia.
  • Zactin Tabs
    Drug - 27 Sep 2024
    Consumer Medicine Information (CMI) about Zactin Tabs intended for persons living in Australia.
  • Zactin Caps
    Drug - 27 Sep 2024
    Consumer Medicine Information (CMI) about Zactin Caps intended for persons living in Australia.
  • Trimethoprim Viatris
    Drug - 26 Sep 2024
    Consumer Medicine Information (CMI) about Trimethoprim Viatris intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback